FEBBO WILLIAM J
SEC insider (Form 3/4/5 filer). CIK 0001413987. Director at MYOMO, INC. (MYO) and 2 other issuers. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 25, 2026. Located in BURLINGTON, MA.
Companies FEBBO WILLIAM J has filed insider reports for
- MYOMO, INC. (MYO): Director
- OptimizeRx Corp (OPRX): Director, Officer, CEO
- Augmedix, Inc. (AUGX): Director
FEBBO WILLIAM J
CIK: 0001413987
Transaction Breakdown
Open Market Buys (P)1 (20.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (40.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (40.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 25, 2026MYO
MYOMO, INC.
AwardDirect78.7K shares- - Apr 14, 2026MYO
MYOMO, INC.
AwardDirect45K shares- - Feb 14, 2025OPRX
OptimizeRx Corp
Tax PaymentDirect401 shares at avg. $6.64$3K - Dec 12, 2024OPRX
OptimizeRx Corp
PurchaseDirect20K shares at avg. $5.01$100K - Oct 2, 2024AUGX
Augmedix, Inc.
DispositionDirect162.6K shares at avg. $2.35$382K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 25, 2026 |  MYO MYOMO, INC. | Award | 78,704 | - | $0 | Direct |
| Apr 14, 2026 | MYO MYOMO, INC. | Award | 45,000 | - | $0 | Direct |
| Feb 14, 2025 |  OPRX OptimizeRx Corp | Tax Payment | 401 | $6.64 | $2,663 | Direct |
| Dec 12, 2024 | OPRX OptimizeRx Corp | Purchase | 20,000 | $5.01 | $100,220 | Direct |
| Oct 2, 2024 |  AUGX Augmedix, Inc. | Disposition | 162,583 | $2.35 | $382,070 | Direct |
1-5 of 5 transactions